Pharmacokinetics, pharmacodynamics and pharmacogenomics of busulphan and other agents used in blood or marrow transplantatio

Not Applicable

Recruiting

• Conditions: acute leukaemia; non-Hodgkin Lymphoma; Multiple myeloma; Pharmacokinetics of various chemotherapeutic agents used as conditioning in allogeneic and autologous transplant recipients; Cancer - Leukaemia - Acute leukaemia; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma; Cancer - Myeloma

• Registration Number: ACTRN12612000544875
• Lead Sponsor: The Children's Hospital at Westmead

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Patients of any age receiving IV busulphan and /or other conditioning agents prior to autologous or allogeneic transplantation to treat both malignant and non-malignant disease.
2. Patients require adequate venous access preferably with a central venous catheter but will be as per institution’s transplant policy
3.Written informed consent

Exclusion Criteria

Those for whom written informed consent cannot be obtained.

Study & Design

• Study Type: Observational
• Study Design: Not specified